Westlake Village, California-based Sienna Biopharmaceuticals, which is focused on medical dermatology and aesthetics, has raised an additional $12 million in its Series A funding, bringing the total tally to about $46 million. The investors in this round included ARCH Venture Partners, Partner Fund Management and Two River.
Source: Press Release
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: